Health-care companies fell as traders rotated out of defensive sectors and back into the tech sector.
Shares of British drug maker AstraZeneca and partner Ionis Pharmaceuticals tumbled after the Wainua drug failed to meet the primary target in a late-stage clinical trial for heart diseas
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
July 09, 2026 17:13 ET (21:13 GMT)






